Beijing SL Pharmaceutical Co., Ltd. is engaged in the research, development, production and operation of genetic engineering and biochemical drugs. Its products include anti-tumor tablets, liver tablets; cardiovascular and osteoporosis medication, recombinant products, small volume injection, freeze-dried powder, capsules, granules, and pharmaceutical raw materials. The company was founded in December 1994 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company